Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet

Shi-Zhong Luo1, Xi Mo, Vahid Afshar-Kharghan

  • 1Center for Membrane Biology, Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, MSB 6.130, 6431 Fannin St, Houston, TX 77030, USA.

Blood
|September 30, 2006
PubMed

Insights

Glycoprotein Ib (GP Ib) has an Ibalpha subunit linked to two Ibbeta subunits via disulfide bonds, not one. This finding revises the structure of the GP Ib-IX-V complex in platelets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • The glycoprotein Ib (GP Ib) complex is crucial for platelet adhesion and aggregation.
  • The precise subunit stoichiometry and disulfide bonding within GP Ib remain incompletely understood.

Purpose of the Study:

  • To elucidate the specific cysteine residues involved in the disulfide bond between Ibalpha and Ibbeta subunits.
  • To determine the stoichiometry of subunits within the GP Ib-IX complex.

Main Methods:

  • Site-directed mutagenesis of cysteine residues in Ibalpha and Ibbeta subunits.
  • Co-immunoprecipitation assays to analyze subunit interactions.
  • Analysis of GP Ib from transfected cells and human platelets.

Main Results:

  • Both C484 and C485 in Ibalpha form disulfide bonds with C122 in Ibbeta.
  • The GP Ib-IX complex contains at least two Ibbeta subunits for every one Ibalpha and one IX subunit.
  • Observed size differences in GP Ib are due to sequence and glycosylation variations in Ibalpha.

Conclusions:

  • The resting platelet GP Ib complex exhibits an Ibalpha(2)Ibbeta(2) composition, challenging previous models.
  • This revised stoichiometry necessitates a re-evaluation of the GP Ib-IX-V complex structure.
  • The alphabeta2 composition suggests potential for disulfide bond rearrangements within the receptor.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...